Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

1.

Teenage booster vaccine: factors affecting uptake.

Crocker J, Porter-Jones G, McGowan A, Roberts RJ, Cottrell S.

J Public Health (Oxf). 2012 Dec;34(4):498-504. doi: 10.1093/pubmed/fds047. Epub 2012 Jun 18.

PMID:
22711912
[PubMed - indexed for MEDLINE]
Free Article
2.

Immune response to a diphtheria and tetanus toxoid administration in a three-dose diphtheria tetanus whole-cell pertussis/enhanced inactivated poliovirus vaccination schedule: a 7-year follow up.

Swartz TA, Saliou P, Catznelson E, Blondeau C, Gil I, Peled T, Havkin O, Fletcher M.

Eur J Epidemiol. 2003;18(8):827-33.

PMID:
12974560
[PubMed - indexed for MEDLINE]
3.
4.

Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.

Black S, Friedland LR, Ensor K, Weston WM, Howe B, Klein NP.

Pediatr Infect Dis J. 2008 Apr;27(4):341-6. doi: 10.1097/INF.0b013e3181616180.

PMID:
18316985
[PubMed - indexed for MEDLINE]
5.

Safety and immunogenicity of a pentavalent diphtheria, tetanus, pertussis, hepatitis B and polio combination vaccine in infants.

Yeh SH, Ward JI, Partridge S, Marcy SM, Lee H, Jing J, Curry ES, Howe BJ.

Pediatr Infect Dis J. 2001 Oct;20(10):973-80.

PMID:
11642632
[PubMed - indexed for MEDLINE]
6.

Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants.

Lagos R, Kotloff K, Hoffenbach A, San Martin O, Abrego P, Ureta AM, Pines E, Blondeau C, Bailleux F, Levine MM.

Pediatr Infect Dis J. 1998 Apr;17(4):294-304.

PMID:
9576383
[PubMed - indexed for MEDLINE]
7.

One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine.

Lin TY, Wang YH, Huang YC, Chiu CH, Lin PY, Chen CJ, Chavand P, Ortiz E.

Int J Infect Dis. 2007 Nov;11(6):488-95. Epub 2007 Mar 8.

PMID:
17349809
[PubMed - indexed for MEDLINE]
Free Article
8.

Booster vaccination and 1-year follow-up of 4-8-year-old children with a reduced-antigen-content dTpa-IPV vaccine.

Sänger R, Behre U, Krause KH, Loch HP, Soemantri P, Herrmann D, Schmitz-Hauss E, Wolter J, Hoet B.

Eur J Pediatr. 2007 Dec;166(12):1229-36. Epub 2007 Jan 18.

PMID:
17235521
[PubMed - indexed for MEDLINE]
9.

Comparison of the tolerability of an acellular pertussis-containing vaccine given as the fifth booster dose in differently primed children.

Kemmeren JM, Timmer SS, van der Maas NA, de Melker HE.

Vaccine. 2011 Jun 10;29(26):4373-7. doi: 10.1016/j.vaccine.2011.04.009. Epub 2011 Apr 22.

PMID:
21514347
[PubMed - indexed for MEDLINE]
10.

A modified vaccine reduces the rate of large injection site reactions to the preschool booster dose of diphtheria-tetanus-acellular pertussis vaccine: results of a randomized, controlled trial.

Scheifele DW, Halperin SA, Ochnio JJ, Ferguson AC, Skowronski DM.

Pediatr Infect Dis J. 2005 Dec;24(12):1059-66. Erratum in: Pediatr Infect Dis J. 2006 Mar;25(3):229.

PMID:
16371866
[PubMed - indexed for MEDLINE]
11.

Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate Vaccine.

Tichmann-Schumann I, Soemantri P, Behre U, Disselhoff J, Mahler H, Maechler G, Sänger R, Jacquet JM, Schuerman L.

Pediatr Infect Dis J. 2005 Jan;24(1):70-7.

PMID:
15665713
[PubMed - indexed for MEDLINE]
12.

A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults.

Thierry-Carstensen B, Jordan K, Uhlving HH, Dalby T, Sørensen C, Jensen AM, Heilmann C.

Vaccine. 2012 Aug 10;30(37):5464-71. doi: 10.1016/j.vaccine.2012.06.073. Epub 2012 Jul 6.

PMID:
22776216
[PubMed - indexed for MEDLINE]
13.

Immunogenicity and safety of a combined DTaP-IPV vaccine compared with separate DTaP and IPV vaccines when administered as pre-school booster doses with a second dose of MMR vaccine to healthy children aged 4-6 years.

Black S, Friedland LR, Schuind A, Howe B; GlaxoSmithKline DTaP-IPV Vaccine Study Group.

Vaccine. 2006 Aug 28;24(35-36):6163-71. Epub 2006 Apr 21.

PMID:
16759769
[PubMed - indexed for MEDLINE]
14.

Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.

Grimprel E, von Sonnenburg F, Sänger R, Abitbol V, Wolter JM, Schuerman LM.

Vaccine. 2005 May 25;23(28):3657-67.

PMID:
15882526
[PubMed - indexed for MEDLINE]
15.

Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants.

Knuf M, Habermehl P, Cimino C, Petersen G, Schmitt HJ.

Vaccine. 2006 May 29;24(22):4727-36. Epub 2006 Mar 24.

PMID:
16616973
[PubMed - indexed for MEDLINE]
16.

Adverse events after school leavers received combined tetanus and low dose diphtheria vaccine.

Ramsay M, Joce R, Whalley J.

Commun Dis Rep CDR Rev. 1997 May 2;7(5):R65-7.

PMID:
9175307
[PubMed - indexed for MEDLINE]
17.

Immunogenicity and reactogenicity of combined acellular pertussis/tetanus/low dose diphtheria vaccines given as a booster to UK teenagers.

Southern J, Andrews N, Burrage M, Miller E.

Vaccine. 2005 May 31;23(29):3829-35. Epub 2005 Mar 30.

PMID:
15893621
[PubMed - indexed for MEDLINE]
18.

Immunogenicity and reactogenicity of acellular diphtheria/tetanus/pertussis vaccines given as a pre-school booster: effect of simultaneous administration of MMR.

Miller E, Waight P, Laurichesse H, Andrews N, Thornton C, Sesardic D, Corbel M.

Vaccine. 2001 Jul 16;19(28-29):3904-11.

PMID:
11427264
[PubMed - indexed for MEDLINE]
19.

Safety and immunogenicity of a primary course and booster dose of a combined diphtheria, tetanus, acellular pertussis, hepatitis B and inactivated poliovirus vaccine.

Meriste S, Lutsar I, Tamm E, Willems P.

Scand J Infect Dis. 2006;38(5):350-6.

PMID:
16709537
[PubMed - indexed for MEDLINE]
20.

Booster vaccination at 6-8 years of age with a reduced antigen content dTpa-IPV vaccine is immunogenic and safe after priming with whole-cell pertussis vaccine.

Lin TY, Wang YH, Huang YC, Chiu CH, Lin PY, Tang H, Hoet B, Bock HL.

Hum Vaccin. 2008 Jan-Feb;4(1):50-3. Epub 2007 Aug 27.

PMID:
18376147
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk